Nifty

:

18638.90

Sensex

:

62970.49

40.25 (0.22%)
124.11 (0.20%)

Login

Nifty
Sensex

:
:

18638.90
62970.49

40.25 (0.22%)
124.11 (0.20%)

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

Rating :

71/99

BSE: 506879 | NSE: GUJTHEMIS

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,084.35
18.71
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,072.00
0.72%
7.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.01
24.24
10.50

EBITDA CAGR (%)

10 Years
5 Years
3 Years

31.91
56.21
12.77

PAT CAGR (%)

10 Years
5 Years
3 Years

44.89
62.33
22.60

P:E (Median)

8 Years
5 Years
3 Years

15.21
12.79
15.36

P:BV (Average)

8 Years
5 Years
3 Years

6.86
6.86
6.95

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.49
9.31
10.78

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 28.17 28.76 -2.05% 28.16 18.60 51.40% 47.69 35.05 36.06% 44.94 32.44 38.53%
Expenses 13.25 15.68 -15.50% 16.05 8.81 82.18% 23.29 16.60 40.30% 22.16 15.72 40.97%
EBITDA 14.93 13.08 14.14% 12.11 9.80 23.57% 24.40 18.45 32.25% 22.78 16.72 36.24%
EBIDTM 52.98% 45.47% 43.00% 52.66% 51.17% 52.63% 50.68% 51.55%
Other Income 1.40 1.51 -7.28% 1.81 0.69 162.32% 1.40 0.72 94.44% 1.42 1.13 25.66%
Interest 0.03 0.18 -83.33% 0.07 0.33 -78.79% 0.04 0.13 -69.23% 0.06 0.20 -70.00%
Depreciation 0.77 0.54 42.59% 0.66 0.57 15.79% 0.58 0.58 0.00% 0.57 0.54 5.56%
PBT 15.53 13.87 11.97% 13.19 9.59 37.54% 25.18 18.46 36.40% 23.57 17.12 37.68%
Tax 3.84 4.08 -5.88% 3.38 2.47 36.84% 6.48 4.67 38.76% 5.80 4.20 38.10%
PAT 11.69 9.79 19.41% 9.81 7.12 37.78% 18.70 13.79 35.61% 17.77 12.92 37.54%
PATM 41.50% 34.03% 34.82% 38.28% 39.21% 39.35% 39.54% 39.84%
EPS 8.06 6.75 19.41% 6.76 4.91 37.68% 12.90 9.51 35.65% 12.26 8.91 37.60%

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 148.96 114.85 90.56 85.12 41.05 38.80 35.69 32.62 31.44 30.23 28.37 Net Sales Growth 29.70% 26.82% 6.39% 107.36% 5.80% 8.71% 9.41% 3.75% 4.00% 6.56% Cost Of Goods Sold 26.48 16.10 15.13 11.05 1.04 2.15 1.48 0.32 0.29 0.29 1.45 Gross Profit 122.48 98.75 75.43 74.07 40.01 36.65 34.21 32.30 31.15 29.94 26.92 GP Margin 82.22% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% 99.02% 99.08% 99.04% 94.89% Total Expenditure 74.75 56.81 50.23 53.29 33.69 32.56 29.64 26.59 25.17 23.72 24.73 Power & Fuel Cost - 21.73 16.57 22.86 20.20 19.33 17.99 17.15 16.16 15.31 15.48 % Of Sales - 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% 52.58% 51.40% 50.65% 54.56% Employee Cost - 7.08 7.11 6.43 5.17 4.46 4.42 4.28 4.00 3.86 3.61 % Of Sales - 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% 13.12% 12.72% 12.77% 12.72% Manufacturing Exp. - 9.00 9.35 10.97 5.67 5.01 4.43 3.58 3.25 3.26 2.98 % Of Sales - 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% 10.97% 10.34% 10.78% 10.50% General & Admin Exp. - 1.32 1.16 0.93 0.95 0.95 0.76 0.77 0.73 0.69 0.86 % Of Sales - 1.15% 1.28% 1.09% 2.31% 2.45% 2.13% 2.36% 2.32% 2.28% 3.03% Selling & Distn. Exp. - 0.31 0.38 0.54 0.32 0.03 0.03 0.00 0.02 0.04 0.04 % Of Sales - 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% 0% 0.06% 0.13% 0.14% Miscellaneous Exp. - 1.26 0.53 0.49 0.35 0.64 0.53 0.49 0.72 0.27 0.04 % Of Sales - 1.10% 0.59% 0.58% 0.85% 1.65% 1.49% 1.50% 2.29% 0.89% 1.09% EBITDA 74.22 58.04 40.33 31.83 7.36 6.24 6.05 6.03 6.27 6.51 3.64 EBITDA Margin 49.83% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% 18.49% 19.94% 21.53% 12.83% Other Income 6.03 4.05 3.27 1.70 2.21 0.17 0.36 0.17 0.09 0.19 0.26 Interest 0.20 0.83 0.98 0.92 0.16 0.42 0.41 0.38 0.39 0.71 0.78 Depreciation 2.58 2.23 1.73 1.36 1.22 1.15 1.12 1.20 1.38 1.46 2.05 PBT 77.47 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 4.53 1.07 Tax 19.50 15.41 10.70 7.58 1.79 0.97 0.51 0.00 0.00 0.00 0.00 Tax Rate 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% 0.00% 0.00% 0.00% 0.00% PAT 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 4.53 1.07 PAT before Minority Interest 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 4.53 1.07 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 38.92% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% 14.19% 14.60% 14.99% 3.77% PAT Growth 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% -5.40% 0.87% 1.32% 323.36% EPS 39.98 30.08 20.81 16.32 4.42 2.67 3.02 3.19 3.17 3.12 0.74

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 103.32 69.95 42.20 18.52 12.11 8.21 3.84 -0.79 -5.34 -9.87 Share Capital 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 96.06 62.68 34.93 11.26 4.85 0.95 -3.42 -8.05 -12.60 -17.13 Non-Current Liabilities 2.02 2.49 4.54 1.43 0.46 1.32 1.52 5.69 6.35 7.33 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.32 1.05 1.78 2.52 3.25 Unsecured Loans 0.00 0.00 3.18 0.00 0.00 0.40 0.00 3.50 3.50 3.76 Long Term Provisions 0.58 0.51 0.49 0.51 0.46 0.55 0.47 0.41 0.33 0.32 Current Liabilities 31.67 25.87 24.29 12.81 7.92 11.90 9.32 9.81 15.03 20.61 Trade Payables 6.62 3.54 7.45 5.60 5.58 7.14 5.51 5.65 5.13 5.94 Other Current Liabilities 8.60 10.87 9.16 7.13 2.28 3.56 3.63 4.13 7.86 11.01 Short Term Borrowings 0.00 0.00 0.00 0.01 0.00 1.14 0.10 0.00 2.00 3.61 Short Term Provisions 16.45 11.46 7.69 0.08 0.06 0.06 0.08 0.04 0.04 0.04 Total Liabilities 137.01 98.31 71.03 32.76 20.49 21.43 14.68 14.71 16.04 18.07 Net Block 19.43 18.95 17.08 14.61 10.59 10.63 9.37 9.71 11.05 12.42 Gross Block 28.24 25.52 21.93 18.10 12.86 11.75 41.61 40.76 42.59 42.50 Accumulated Depreciation 8.81 6.57 4.85 3.49 2.27 1.12 32.24 31.05 31.54 30.07 Non Current Assets 44.11 24.94 34.94 24.72 12.65 13.18 11.47 11.24 12.69 14.16 Capital Work in Progress 12.70 2.07 0.36 0.95 0.17 0.20 0.04 0.03 0.13 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 2.77 2.61 2.38 2.45 1.62 2.08 1.74 1.29 1.28 1.72 Other Non Current Assets 9.21 1.31 15.12 6.71 0.27 0.27 0.32 0.20 0.23 0.01 Current Assets 92.90 73.37 36.08 8.04 7.84 8.25 3.21 3.48 3.34 3.90 Current Investments 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Inventories 11.61 6.05 6.03 0.34 0.46 0.51 0.42 0.33 0.45 0.23 Sundry Debtors 25.12 14.71 20.23 5.80 2.72 6.99 2.16 2.37 1.24 2.87 Cash & Bank 12.35 27.64 2.08 1.70 4.46 0.41 0.19 0.23 0.90 0.26 Other Current Assets 43.82 1.98 0.30 0.15 0.20 0.35 0.44 0.54 0.76 0.53 Short Term Loans & Adv. 42.06 22.98 7.44 0.05 0.06 0.21 0.32 0.31 0.31 0.10 Net Current Assets 61.23 47.50 11.80 -4.77 -0.08 -3.65 -6.11 -6.33 -11.69 -16.71 Total Assets 137.01 98.31 71.02 32.76 20.49 21.43 14.68 14.72 16.03 18.06

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 40.31 10.53 0.63 0.69 5.59 2.80 3.91 2.71 4.30 0.46 PBT 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 4.53 1.07 Adjustment 0.15 -0.24 0.65 -3.92 1.44 1.48 1.58 2.03 2.07 2.71 Changes in Working Capital -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 -1.70 -3.69 -2.23 -2.72 Cash after chg. in Working capital 54.83 20.66 7.60 1.83 6.17 3.43 4.51 2.93 4.37 1.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 -0.52 -0.19 -0.09 -0.54 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 -0.02 0.02 -0.06 Cash From Investing Activity -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 -0.78 -0.29 -0.33 -2.88 Net Fixed Assets -13.35 -5.30 -3.24 -6.02 -1.08 29.70 -0.86 1.93 -0.22 -2.69 Net Investments 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -16.48 3.04 0.26 0.27 0.05 -32.21 0.08 -2.22 -0.11 -0.19 Cash from Financing Activity -14.00 -5.16 2.10 5.29 -3.80 -0.19 -3.15 -3.13 -3.33 1.97 Net Cash Inflow / Outflow -3.51 3.12 -0.26 0.23 0.76 0.10 -0.01 -0.71 0.63 -0.44 Opening Cash & Equivalents 3.97 0.86 1.12 0.89 0.13 0.03 0.04 0.75 0.12 0.57 Closing Cash & Equivalent 0.46 3.97 0.86 1.12 0.89 0.13 0.03 0.04 0.75 0.12

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 71.11 48.14 29.04 12.75 8.34 5.65 2.65 -0.54 -3.68 -6.79 ROA 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% 31.50% 29.88% 26.54% 6.02% ROE 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% 302.71% 0.00% 0.00% 0.00% ROCE 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% 80.38% 113.74% 209.07% 0.00% Fixed Asset Turnover 4.27 3.82 4.25 2.65 3.15 1.34 0.79 0.75 0.71 0.70 Receivable days 63.29 70.42 55.80 37.88 45.67 46.80 25.38 20.96 24.84 34.72 Inventory Days 28.06 24.34 13.65 3.55 4.57 4.73 4.19 4.57 4.13 6.04 Payable days 115.10 132.50 42.12 60.55 72.03 77.99 76.35 77.95 82.95 84.95 Cash Conversion Cycle -23.75 -37.74 27.33 -19.12 -21.79 -26.47 -46.78 -52.42 -53.97 -44.19 Total Debt/Equity 0.00 0.04 0.19 0.32 0.05 0.49 0.86 -7.74 -1.65 -1.16 Interest Cover 72.31 42.66 34.85 52.71 12.59 12.96 13.26 12.86 7.33 2.37

Top Investors:

jitendra baldwa

dipak kanayalal shah

Annual Reports:

News Update:

Guj. Themis Biosyn - Quarterly Results
13th May 2023, 13:42 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback